Deutsche Bank
CRBU icon

Deutsche Bank’s Caribou Biosciences CRBU Stock Holding History

Deutsche Bank’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-49,576
Closed -$45.1K – 3629
2025
Q1 		$45.1K Hold
49,576
– – ﹤0.01% 3392
2024
Q4 		$78.8K Hold
49,576
– – ﹤0.01% 3353
2024
Q3 		$97.2K Buy
49,576
+19,597
+65% +$40.1K ﹤0.01% 3229
2024
Q2 		$49.2K Sell
29,979
-5,693
-16% -$18.2K ﹤0.01% 3330
2024
Q1 		$183K Buy
35,672
+785
+2% +$4.84K ﹤0.01% 2870
2023
Q4 		$200K Buy
34,887
+5,477
+19% +$27.1K ﹤0.01% 2881
2023
Q3 		$141K Buy
29,410
+6,392
+28% +$39.7K ﹤0.01% 2998
2023
Q2 		$97.8K Sell
23,018
-11,831
-34% -$53.2K ﹤0.01% 3282
2023
Q1 		$185K Buy
34,849
+9,814
+39% +$61.1K ﹤0.01% 3044
2022
Q4 		$157K Buy
25,035
+3,017
+14% +$26.8K ﹤0.01% 3091
2022
Q3 		$232K Sell
22,018
-921
-4% -$8.58K ﹤0.01% 2860
2022
Q2 		$125K Sell
22,939
-4,187
-15% -$32K ﹤0.01% 3407
2022
Q1 		$249K Buy
27,126
+14,112
+108% +$149K ﹤0.01% 3136
2021
Q4 		$196K Buy
13,014
+1,296
+11% +$25.2K ﹤0.01% 3397
2021
Q3 		$279K Buy
+11,718
New +$286K ﹤0.01% 3386

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's CRBU Position: Q2 2025 in Review

Deutsche Bank sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 49,576 shares — an estimated $45.1K sold.

Deutsche Bank first reported a position in CRBU in Q3 2021 and held it in 15 quarters. The position peaked at $279K in Q3 2021. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • Deutsche Bank reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 49,576 Caribou Biosciences shares in Q2 2025, an estimated $45.1K.
  • Deutsche Bank first reported a position in Caribou Biosciences in Q3 2021 and held it in 15 quarters.
  • Deutsche Bank's Caribou Biosciences position peaked at $279K in Q3 2021.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.